• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Diagnostics (Basel) . Development and Validation of an Automated Radiomic CT Signature for Detecting COVID-19

tetano

Editor, Senior Moderator
Diagnostics (Basel)


. 2020 Dec 30;11(1):E41.
doi: 10.3390/diagnostics11010041.
Development and Validation of an Automated Radiomic CT Signature for Detecting COVID-19


Julien Guiot[SUP] 1 [/SUP], Akshayaa Vaidyanathan[SUP] 2 3 [/SUP], Louis Deprez[SUP] 4 [/SUP], Fadila Zerka[SUP] 2 3 [/SUP], Denis Danthine[SUP] 4 [/SUP], Anne-No?lle Frix[SUP] 1 [/SUP], Marie Thys[SUP] 5 [/SUP], Monique Henket[SUP] 1 [/SUP], Gregory Canivet[SUP] 6 [/SUP], Stephane Mathieu[SUP] 6 [/SUP], Evanthia Eftaxia[SUP] 4 [/SUP], Philippe Lambin[SUP] 3 [/SUP], Nathan Tsoutzidis[SUP] 2 [/SUP], Benjamin Miraglio[SUP] 2 [/SUP], Sean Walsh[SUP] 2 [/SUP], Michel Moutschen[SUP] 7 [/SUP], Renaud Louis[SUP] 1 [/SUP], Paul Meunier[SUP] 4 [/SUP], Wim Vos[SUP] 2 [/SUP], Ralph T H Leijenaar[SUP] 2 [/SUP], Pierre Lovinfosse[SUP] 8 [/SUP]



Affiliations

Abstract

The coronavirus disease 2019 (COVID-19) outbreak has reached pandemic status. Drastic measures of social distancing are enforced in society and healthcare systems are being pushed to and beyond their limits. To help in the fight against this threat on human health, a fully automated AI framework was developed to extract radiomics features from volumetric chest computed tomography (CT) exams. The detection model was developed on a dataset of 1381 patients (181 COVID-19 patients plus 1200 non COVID control patients). A second, independent dataset of 197 RT-PCR confirmed COVID-19 patients and 500 control patients was used to assess the performance of the model. Diagnostic performance was assessed by the area under the receiver operating characteristic curve (AUC). The model had an AUC of 0.882 (95% CI: 0.851-0.913) in the independent test dataset (641 patients). The optimal decision threshold, considering the cost of false negatives twice as high as the cost of false positives, resulted in an accuracy of 85.18%, a sensitivity of 69.52%, a specificity of 91.63%, a negative predictive value (NPV) of 94.46% and a positive predictive value (PPV) of 59.44%. Benchmarked against RT-PCR confirmed cases of COVID-19, our AI framework can accurately differentiate COVID-19 from routine clinical conditions in a fully automated fashion. Thus, providing rapid accurate diagnosis in patients suspected of COVID-19 infection, facilitating the timely implementation of isolation procedures and early intervention.

Keywords: COVID-19; artificial intelligence; computed tomography; machine learning; radiomics.
 
Back
Top Bottom